NELSEN ROBERT

Average Profitability
19.53%
Insider Buys Quantity
7
Insider Buys Sum
$89.3M
Insider Sells Quantity
7
Insider Sells Sum
$20.75M

Insider Activity of NELSEN ROBERT

According to the SEC Form 4 filings, NELSEN ROBERT, being in a position of

  1. at Prime Medicine, Inc.,
    оver the last 12 months, has bought 3200000 shares for $20M, and sold 0 shares,
    over all time since 2022-10-24, has bought 3600000 shares for $26.8M, and sold 0 shares.

The largest purchase of all time was on 2019-10-16 and amounted to 2000000 shares of Vir Biotechnology, Inc. for $40M.

The largest sale of all time was on 2017-02-27 and amounted to 195223 shares of Agios Pharmaceuticals, Inc. for $9.62M.

Biography of NELSEN ROBERT

No biography is available at this moment.

2024-02-15PurchasePrime Medicine, Inc.
PRME
3.2M
4.6348%
$6.25$20M-36.86%
2024-02-08PurchaseSana Biotechnology, Inc.
SANA
1.09M
0.5382%
$5.50$6M-0.81%
2022-10-24PurchasePrime Medicine, Inc.
PRME
director
400,000
1.5758%
$17.00$6.8M-3.68%
2019-10-16PurchaseVir Biotechnology, Inc.
VIR
2M
8.9051%
$20.00$40M+115.34%
2017-03-06SaleAgios Pharmaceuticals, Inc.
AGIO
director
40
<0.0001%
$49.43$1,977+18.25%
2017-03-03SaleAgios Pharmaceuticals, Inc.
AGIO
director
40,559
0.0957%
$50.85$2.06M+15.64%
2017-02-28SaleAgios Pharmaceuticals, Inc.
AGIO
director
47,859
0.1163%
$49.77$2.38M+21.08%
2017-02-27SaleAgios Pharmaceuticals, Inc.
AGIO
director
195,223
0.4516%
$49.26$9.62M+16.4%
2017-02-23SaleAgios Pharmaceuticals, Inc.
AGIO
director
50,996
0.1219%
$47.90$2.44M+23.2%
2017-02-22SaleAgios Pharmaceuticals, Inc.
AGIO
director
47,938
0.1155%
$49.91$2.39M+19.05%
2017-02-21SaleAgios Pharmaceuticals, Inc.
AGIO
director
36,430
0.0867%
$50.73$1.85M+15.51%
2016-07-06PurchaseSyros Pharmaceuticals, Inc.
SYRS
400,000
1.2619%
$12.50$5M-24.03%
2013-10-04PurchaseFate Therapeutics, Inc.
FATE
1.67M
6.8738%
$6.00$10M-9.51%
2004-03-19PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
director, 10 percent owner
187,500
0.6189%
$8.00$1.5M-10.99%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.